In addition, RCN1 was found to be an ER‐resident protein that transduces the c‐MYC pathway by way of the IRE1α–XBP1s signaling pathway and induces resistance to sorafenib and malignant tumor growth in hepatocellular carcinoma [83]. The gene discussed is ERN1; the disease is neoplasm.